Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tanezumab
Biotech
Lilly, Pfizer stop study of arthritis drug after FDA rejection
After seeing regulators on both sides of the Atlantic knock back filings, Eli Lilly and Pfizer have stopped global clinical development of tanezumab.
Nick Paul Taylor
Oct 26, 2021 9:20am
Pfizer-Lilly's tanezumab hit by 'concerning' safety risks: FDA
Mar 22, 2021 10:25am
Lilly, Pfizer's pain data show mixed efficacy, safety issues
Apr 19, 2019 8:24am
Pfizer, Lilly’s NGF painkiller meets endpoints in low back pain
Feb 19, 2019 10:53am
Pfizer/Lilly NGF pain drug wins again, but safety issue lingers
Jan 29, 2019 9:51am
Pfizer/Lilly showcase data for NGF pain drug tanezumab at ACR
Oct 24, 2018 10:10am
